# Humacyte, Inc.: Form 8-K, filed Feb 17, 2021

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: 8-K
- Filed: 2021-02-17
- Accepted by EDGAR: Feb 17, 2021, 08:45 ET
- Period: 2021-02-17
- Accession: 0001213900-21-009957
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000121390021009957/ea135854-8k_alphahealth.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000121390021009957/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000121390021009957/ea135854-8k_alphahealth.htm

Filed Feb 17, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-009957. Last ingested by Listed: Nov 11, 2026, 01:52 ET. No prices; not investment advice.
